MedRhythms, Inc.

Investment

  • NMTC Amount: $3,974,956
  • Total Project Cost: $24,974,956

IMPACT

  • 18 FTE jobs
  • Jobs must exceed 1.2X the living wage in the region and offer quality benefits, which include, but not limited to medical insurance, paid time off, and wealth creation options.

Investor

Project Description

MedRhythms is the developer of a digital therapeutics platform to deliver rhythmic auditory stimulation therapy to chronic stroke survivors. While RAS therapy typically takes place in a clinical setting, MedRhythms’s product will provide the same experience in the patient’s home. This project provided the Company with working capital to continue MedRhythm’s growth in Maine.

MAP

Address: 183 Middle Street, Suite 300, Portland, ME 4101

Census Tract: 23005000300

Other Maine Projects

NMTC investments raise the profile of rural Maine as a premier, nature-based tourism destination.
NTMC financing funded Educare Central Maine, the first Educare site in New England.

MedRhythms, Inc. (“MedRhythms”) is a digital therapeutics company using sensors, software, and music to deliver Auditory-Motor Entrainment (“AME”) therapy to chronic stroke survivors. Rhythmic auditory stimulation unconsciously synchronizes with the

An existing successful vertically-integrated, third-generation family owned white wood pellet manufacturing and timberland business based on a 55-acre site in rural Athens, ME, added a new all-in-one biomass processor, boiler